DILCONTIN

This brand name is authorized in Nigeria.

Active ingredients

The drug DILCONTIN contains one active pharmaceutical ingredient (API):

1	Diltiazem UNII OLH94387TE - DILTIAZEM HYDROCHLORIDE
	Diltiazem is a calcium antagonist. It restricts the slow channel entry of calcium into the cell and so reduces the liberation of calcium from stores in the sarcoplasmic reticulum. This results in a reduction of the amount of available intracellular calcium reducing myocardial oxygen consumption.
	Read more about Diltiazem

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-5844	Tablet	Dilcontin XL 90 Tablet TAB 90 mg 10 x 10's (in Aluminum Strips)	Controlled Release Tablets (Oral dosage form). Each tablet contains: Diltiazem Hydrochloride 90 mg. Excipients: Hydroxyethyl Cellulose (Natrosol 250 HX) 67.5 mg; Cetostearyl Alcohol (Kolliwax CSA 50) 42.525 mg; Ethyl Cellulose 10 CPS 9.975 mg; Purified Talc 8.025 mg; Magnesium Stearate 8.025 mg	26/04/2023
A4-8231	Tablet	Dilcontin XL 120 TAB 120 mg 10 x 10's (in Aluminum Strips)	Controlled Release Tablets (Oral dosage form)	28/01/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C08DB01	Diltiazem	C Cardiovascular system → C08 Calcium channel blockers → C08D Selective calcium channel blockers with direct cardiac effects → C08DB Benzothiazepine derivatives
Discover more medicines within C08DB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-5844, A4-8231